| Dr Kerrie J Spoonemore, MD | |
|
3216 Ne 45th Pl, Suite 203, Seattle, WA 98105-4093 | |
| (205) 525-1168 | |
| (206) 525-1169 |
| Full Name | Dr Kerrie J Spoonemore |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 3216 Ne 45th Pl, Seattle, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063401305 | NPI | - | NPPES |
| 8433757 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD00044804 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silver Falls Dermatology Llc | 5890863492 | 84 |
News Archive
For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.
Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.
In the October 20th edition of the journal Cell Host and Microbe, Drs. Claudia Plottel and Martin J. Blaser of the Departments of Medicine and Microbiology at NYU Langone Medical Center, and the Department of Biology at New York University, present a model for understanding how cancer evolves in humans based on an understanding of the bacteria living in our body, the microbiome.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2013, and provided a business update.
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company through its wholly owned subsidiary, B&R Acquisition Company, for all of the outstanding shares of common stock of Amylin Pharmaceuticals, Inc. at a purchase price of $31.00 per share.
› Verified 6 days ago
| Entity Name | Reichel Dermatology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548214 PECOS PAC ID: 9931119138 Enrollment ID: O20060907000592 |
News Archive
For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.
Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.
In the October 20th edition of the journal Cell Host and Microbe, Drs. Claudia Plottel and Martin J. Blaser of the Departments of Medicine and Microbiology at NYU Langone Medical Center, and the Department of Biology at New York University, present a model for understanding how cancer evolves in humans based on an understanding of the bacteria living in our body, the microbiome.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2013, and provided a business update.
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company through its wholly owned subsidiary, B&R Acquisition Company, for all of the outstanding shares of common stock of Amylin Pharmaceuticals, Inc. at a purchase price of $31.00 per share.
› Verified 6 days ago
| Entity Name | Silver Falls Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134375421 PECOS PAC ID: 5890863492 Enrollment ID: O20140328000678 |
News Archive
For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.
Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.
In the October 20th edition of the journal Cell Host and Microbe, Drs. Claudia Plottel and Martin J. Blaser of the Departments of Medicine and Microbiology at NYU Langone Medical Center, and the Department of Biology at New York University, present a model for understanding how cancer evolves in humans based on an understanding of the bacteria living in our body, the microbiome.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2013, and provided a business update.
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company through its wholly owned subsidiary, B&R Acquisition Company, for all of the outstanding shares of common stock of Amylin Pharmaceuticals, Inc. at a purchase price of $31.00 per share.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kerrie J Spoonemore, MD 3216 Ne 45th Pl, Suite 203, Seattle, WA 98105-4093 Ph: (205) 525-1168 | Dr Kerrie J Spoonemore, MD 3216 Ne 45th Pl, Suite 203, Seattle, WA 98105-4093 Ph: (205) 525-1168 |
News Archive
For the first time a research team at Charité - Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease.
Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.
In the October 20th edition of the journal Cell Host and Microbe, Drs. Claudia Plottel and Martin J. Blaser of the Departments of Medicine and Microbiology at NYU Langone Medical Center, and the Department of Biology at New York University, present a model for understanding how cancer evolves in humans based on an understanding of the bacteria living in our body, the microbiome.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2013, and provided a business update.
Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company through its wholly owned subsidiary, B&R Acquisition Company, for all of the outstanding shares of common stock of Amylin Pharmaceuticals, Inc. at a purchase price of $31.00 per share.
› Verified 6 days ago
Dr. Fan Liu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4225 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-543-5290 Fax: 206-543-2489 | |
Ulrike I Ochs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Dr. Ravi S Krishnan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-8806 Fax: 206-341-1910 | |
Ms. Ardeth Lazz Dunne, PAC Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1730 Minor Avenue, Ste 1000 Dermatology Associates Pllc, Seattle, WA 98101 Phone: 206-267-2100 Fax: 206-267-2101 | |
Virginia P Sybert, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-616-2135 | |
Dr. Tanya Kaur Greywal, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 |